Elimination af hepatitis C-virus i Danmark

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Elimination af hepatitis C-virus i Danmark. / Døssing, Anna; Røge, Birgitte Thorup; Madsen, Lone Galmstrup; Laursen, Alex Lund; Hansen, Jesper Bach; Bukh, Jens; Weis, Nina.

I: Ugeskrift for Laeger, Bind 182, Nr. 9, 2020.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Døssing, A, Røge, BT, Madsen, LG, Laursen, AL, Hansen, JB, Bukh, J & Weis, N 2020, 'Elimination af hepatitis C-virus i Danmark', Ugeskrift for Laeger, bind 182, nr. 9. <https://ugeskriftet.dk/files/scientific_article_files/2020-02/v08190481_0.pdf>

APA

Døssing, A., Røge, B. T., Madsen, L. G., Laursen, A. L., Hansen, J. B., Bukh, J., & Weis, N. (2020). Elimination af hepatitis C-virus i Danmark. Ugeskrift for Laeger, 182(9). https://ugeskriftet.dk/files/scientific_article_files/2020-02/v08190481_0.pdf

Vancouver

Døssing A, Røge BT, Madsen LG, Laursen AL, Hansen JB, Bukh J o.a. Elimination af hepatitis C-virus i Danmark. Ugeskrift for Laeger. 2020;182(9).

Author

Døssing, Anna ; Røge, Birgitte Thorup ; Madsen, Lone Galmstrup ; Laursen, Alex Lund ; Hansen, Jesper Bach ; Bukh, Jens ; Weis, Nina. / Elimination af hepatitis C-virus i Danmark. I: Ugeskrift for Laeger. 2020 ; Bind 182, Nr. 9.

Bibtex

@article{5007d1c4b0fa43aca43632057e5dace9,
title = "Elimination af hepatitis C-virus i Danmark",
abstract = "In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.",
author = "Anna D{\o}ssing and R{\o}ge, {Birgitte Thorup} and Madsen, {Lone Galmstrup} and Laursen, {Alex Lund} and Hansen, {Jesper Bach} and Jens Bukh and Nina Weis",
year = "2020",
language = "Dansk",
volume = "182",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "9",

}

RIS

TY - JOUR

T1 - Elimination af hepatitis C-virus i Danmark

AU - Døssing, Anna

AU - Røge, Birgitte Thorup

AU - Madsen, Lone Galmstrup

AU - Laursen, Alex Lund

AU - Hansen, Jesper Bach

AU - Bukh, Jens

AU - Weis, Nina

PY - 2020

Y1 - 2020

N2 - In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.

AB - In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.

M3 - Tidsskriftartikel

C2 - 32138816

VL - 182

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 9

ER -

ID: 260601345